Research Article | Open Access
Carene M. N. Picot, A. Hussein Subratty, M. Fawzi Mahomoodally, "Inhibitory Potential of Five Traditionally Used Native Antidiabetic Medicinal Plants on α-Amylase, α-Glucosidase, Glucose Entrapment, and Amylolysis Kinetics In Vitro", Advances in Pharmacological and Pharmaceutical Sciences, vol. 2014, Article ID 739834, 7 pages, 2014. https://doi.org/10.1155/2014/739834
Inhibitory Potential of Five Traditionally Used Native Antidiabetic Medicinal Plants on α-Amylase, α-Glucosidase, Glucose Entrapment, and Amylolysis Kinetics In Vitro
Five traditionally used antidiabetic native medicinal plants of Mauritius, namely, Stillingia lineata (SL), Faujasiopsis flexuosa (FF), Erythroxylum laurifolium (EL), Elaeodendron orientale (EO), and Antidesma madagascariensis (AM), were studied for possible α-amylase and α-glucosidase inhibitory property, glucose entrapment, and amylolysis kinetics in vitro. Only methanolic extracts of EL, EO, and AM (, , and μg/mL, resp.) were found to significantly () inhibit α-amylase and were comparable to acarbose. EL, EO, AM, and SL extracts (5000 μg/mL) were found to significantly () inhibit α-glucosidase (between and % inhibition). Enzyme kinetic studies showed an uncompetitive and mixed type of inhibition. Extracts showed significant () glucose entrapment capacities (8 to 29% glucose diffusion retardation index (GDRI)), with SL being more active (29% GDRI) and showing concentration-dependent activity (29, 26, 21, 14, and 5%, resp.). Amylolysis kinetic studies showed that methanolic extracts were more potent inhibitors of α-amylase compared to aqueous extracts and possessed glucose entrapment properties. Our findings tend to provide justification for the hypoglycaemic action of these medicinal plants which has opened novel avenues for the development of new phytopharmaceuticals geared towards diabetes management.
Phytomedicine also known as herbal medicine has become a mainstream phenomenon worldwide. Recently, it has been reported that more than 80% of the world population is dependent on herbal medicine . The utilisation of plants and their derivatives for the treatment and/or management of various diseases, including diabetes mellitus (DM), is becoming more and more prominent in pharmaceutical markets as an alternative and/or complementary therapy. DM is a growing epidemic and is highly prevalent in Mauritius with at least one out of two adults aged between 25 and 74 years being prediabetic or diabetic [2, 3].
The fundamental defect in DM is the lack of insulin which results in the impairment in glucose uptake, storage, and utilisation . Type 2 DM is the most common form of diabetes and is usually caused by life-style factors and also related to insufficient insulin production and resistance of target tissues to insulin. Several research works have been undertaken to elucidate the possible biochemical mechanisms involved in the pathogenesis of type 2 DM, but the exact mechanism is still unclear. However, hyperglycaemia, the hallmark of type 2 DM, has been considered as the principal cause of diabetes complications. Indeed, it was observed that strict glycaemic control lowered the incidence of retinopathy, nephropathy and neuropathy [5, 6].
Recently, there have been a growing number of scientific publications on the potential antidiabetic action of medicinal plants . Indeed, advances in understanding the activity of key carbohydrate metabolising enzymes such as α-amylase and the role of dietary fibers have led to the development of new pharmacologic agents. Existing hypoglycemic agents such as metformin, voglibose, acarbose and miglitol effectively control glycemic level but carry prominent gastrointestinal side effects. The search for inhibitors devoid of side effects has been geared towards natural resources, namely, medicinal plants [8, 9]. Polyphenolic agents in plants have been shown to inhibit digestive enzymes due to their ability to bind to enzyme protein . Moreover, the role of dietary fibres and viscous polysaccharides in the reduction of postprandial plasma glucose level in diabetic patients is highly documented .
The local population has a deep-rooted interest in the use of medicinal plants. Although a free advanced health care system exists, many Mauritians still rely on the use of folk medicine for the management of diabetes and related complications [7, 12]. Nonetheless, the majority of traditional antidiabetic medicinal plants await proper scientific and medical evaluation. In the present study selected medicinal plants of Mauritius were evaluated for their possible α-amylase and α-glucosidase inhibitory property, glucose movement entrapment and amylolysis kinetics effects using a battery of in vitro bioassays.
2. Materials and Method
2.1. Plant Materials and Extraction
Native traditionally used antidiabetic medicinal plants of Mauritius, namely, Stillingia lineata Lam. (Euphorbiaceae) (SL), Faujasiopsis flexuosa Lam. (Asteraceae) (FF), Erythroxylum laurifolium Lam. (Erythroxylaceae) (EL), Elaeodendron orientale Jacq. (Celastraceae) (EO), and Antidesma madagascariensis Lam. (Euphorbiaceae) (AM), were collected from a natural reserve situated on the upper humid regions of the island. The identity of the plants was confirmed by the natural reserve curator. The harvested plant materials were thoroughly washed under running tap water and air-dried until a constant weight was obtained. Subsequently, the dried samples were ground (Pacific mixer grinder, India) and stored in a cool-dry place prior to extraction. Crude methanolic extracts were obtained by soaking the dry powdered material into 70% methanol (1 : 10, sample : solvent w/v) for 72 h. Aqueous extracts, were prepared following traditional decoction method. Briefly, dried powdered material (50 g) was boiled into distilled water (200 mL) for 30 min. The filtrates were concentrated in vacuo using a rotary evaporator (Rotavap Stuart Scientific Ltd, Staffordshire, UK). The resulting paste-like material was stored at −20°C or dissolved in appropriate solvents.
2.2. α-Amylase Inhibition Assay
α-Amylase activity was assessed using the modified starch-iodine colour change method described previously by Mahomoodally et al.  and Kotowaroo et al. . Briefly, 100 μL α-amylase solution from porcine origin (13 U/mL in 0.1 M sodium acetate buffer pH 7.2) was added to 3 mL soluble starch solution (1 g soluble starch was suspended into 10 mL distilled water and boiled for 2 min. The volume was then made up to 100 mL with distilled water. The starch solution was used within 2-3 days) and 2 mL sodium acetate buffer (0.1 M, pH 7.2). The reaction mixture was incubated for 37°C for 1 h. At timed interval ( min and min) aliquot (0.1 mL) from the reaction mixture was discharged into 10 mL iodine solution. After mixing, the absorbance of the starch-iodine solution was measured at 565 nm. As previously described  one unit of enzyme inhibitor was defined as that which reduced amylase activity by one unit and defined as ; A0 and At being absorbance of starch-iodine solution at t = 0 min and t = 60 min, respectively. For assessing the potential inhibitory activity of graded concentrations of plant extracts (5000–312.5 μg/mL) 100 μL extract was preincubated with 100 μL enzyme solution at 37°C for 15 min. The assay was then conducted as described above. Substrate and amylase blanks were carried out under similar assay conditions. The specific activity of amylase was described as U/mg protein/h.
2.3. Kinetics of α-Amylase Inhibition
A calibration curve using graded glucose concentration (10–0.156 mg/mL) was set up. Glucose solution (3 mL) was added to 3 mL dinitrosalicylic acid (DNS) reagent solution at 1% (10 g DNS, 0.5 g sodium disulphite, and 10 g sodium hydroxide) to capped tubes. The tubes were then placed in boiling water for 5–15 min until a reddish brown colour developed. Sodium potassium tartrate (1 mL, 40%) was then added to the mixture. After cooling, the absorbance was measured at 575 nm. The mode of inhibition of plant extracts on α-amylase action was determined by increasing the substrate (starch) concentration. The amount of glucose released after exactly 3 min was quantified using DNS reagent solution. 0.5 mL graded starch solution (4–0.25%), plant extract (0.25 mL; 5000 μg/mL) and α-amylase solution (0.25 mL; 13 U/mL) were allowed to react for 3 min at 37°C. DNS solution (2 mL) was then added to stop the reaction and the mixture was placed in a boiling water bath for 5–15 min. Sodium potassium tartrate (1 mL, 40%) was then added and absorbance was measured at 575 nm using a spectrophotometer . Kinetic parameters namely, the Michaelis-Menten constant affinity () and maximum velocity (), were derived from appropriate Lineweaver-Burk plots.
2.4. α-Glucosidase Inhibition Assay
α-Glucosidase inhibition was assessed using modified methods previously described by Bachhawat et al.  and Mayur et al. . Briefly, 10 μL α-glucosidase (1 U/mL), 50 μL sodium phosphate buffer (0.1 M, pH 6.9), and 20 μL p-nitrophenol-α-D-glucopyranoside (PNPG) substrate (1 mM) were incubated at 37°C for 30 min. After the incubation period, 50 μL sodium carbonate (0.1 M) was added to the reaction mixture to terminate the reaction. The hydrolysis of PNPG to p-nitrophenol was monitored using an ELISA microplate reader at 405 nm. The IC50 value and % inhibition of glucosidase were calculated as % inhibition = ; is absorbance of the blank and is absorbance of the sample.
2.5. α-Glucosidase Kinetic Studies
The type of inhibition of plant extracts on α-glucosidase action was determined by increasing PNPG concentration following the modified method of Gurudeeban et al. . Graded concentrations of p-nitrophenol (0.6–0.019 mM) were allowed to react with sodium carbonate and the absorbance was measured at 405 nm. Plant extract (20 μL; 5000 μg/mL) was incubated with 10 μL α-glucosidase solution (1 U/mL), 50 μL sodium phosphate buffer (0.1 M, pH 6.9), and 20 μL graded concentrations of PNPG (1.25–0.039 mM) for 10 min at 37°C. The reaction was terminated by adding 50 μL sodium carbonate (0.1 M). Kinetic parameters, namely, the Michaelis-Menten constants affinity () and maximum velocity (), were derived from appropriate Lineweaver-Burk plots.
2.6. Glucose Movement
A simple model system was used to evaluate the effect of the plant extracts on glucose movement in vitro. This model was adapted from a method described by Shaukat et al. . Briefly, the model used in the present experiment consisted of a one-sided sealed dialysis tube (15 cm × 25 mm, dialysis tubing membrane Sigma-Aldrich MW12173) into which 2 mL of 22 mM D-glucose in 0.15 M NaCl and 1 mL extract (160 mg/mL)/control (water) were incorporated. The other end was then sealed and the membrane was placed into a conical flask containing 45 mL 0.15 M NaCl. The conical flask was placed into an orbital shaking incubator (SI50, UK) at 37°C and speed of 100 rotations per minute. Aliquot (10 μL) of the external solution was withdrawn at timed intervals and tested for the presence of glucose using a glucose oxidase kit (Biosystems, Spain). As described by Gallagher et al.  concentration-dependent effect of plant extracts (160, 80, 40, 20, and 10 mg crude extract/mL) that exhibited the highest glucose diffusion retardation index was also evaluated. A standard curve was drawn using different glucose concentrations. Experiments were conducted in triplicate. The glucose diffusion retardation index (GDRI) was calculated using the following formula.
GDRI = (100 glucose content (mg/mL) in external solution in the presence of plant extract/glucose content (mg/mL) in external solution in the absence of plant extract) * 100.
2.7. Amylolysis Kinetics
This assay was adapted from Ahmed et al. . Briefly, 8 g of soluble starch was dissolved in approximately 20 mL 0.1 M phosphate buffer (pH 6.5). The solution was boiled for 3 min and was made up to a final volume 100 mL to give an 8% (w/v) starch solution. The sample-α-amylase-starch system comprised extract (1 mL, 160 mg/mL), freshly prepared starch solution (3 mL, 8%), and enzyme solution (0.1% in 0.1 M phosphate buffer pH 6.5). The test system was dialysed against 45 mL distilled water at 37°C. The glucose concentration of the dialysate was monitored every hour for 4 h using a glucose oxidase kit (Biosystems, Spain). A control test was carried out with and without acarbose, a standard α-amylase inhibitor. After 4 h, the amount of starch remaining inside the dialysis tubing was quantified. To 5 mL iodine solution (0.254 g iodine and 4 g potassium iodide were dissolved in 1 L distilled water), 0.1 mL test mixture was added. The solution was vortexed and the absorbance was read at 565 nm. Then, using a calibration curve (4–0.125% starch solution) the amount of starch was quantified.
2.8. Statistical Analysis
Results were expressed as mean ± standard deviation of three independent determinations. Difference between the samples and controls was determined using one-way analysis of variance (ANOVA) with statistical significance considered as using SPSS 16.0.
3.1. α-Amylase Inhibition Assay
Data from the present study showed the variable inhibitory effect of tested plant extracts on α-amylase activity in vitro. Methanolic extracts of EL, EO, and AM were found to significantly () inhibit α-amylase at different doses. IC50 values of extracts (methanolic EL, EO, and AM) are summarised in Table 1. As illustrated in Table 1, extracts activity (IC50 1745.58–7472.92 μg/mL) was found to be significantly lower compared to positive standard acarbose (1100 μg/mL). In contrast, no dose-dependent response was observed for the other tested extracts (data not shown).
|Data represents the mean ± standard deviation of triplicate values. aValues significantly lower () than positive control (acarbose). |
3.2. α-Amylase Kinetic Studies
Since activity was observed for EL, EO, and AM methanolic extracts, kinetic studies were performed on these extracts. Methanolic EO and AM extracts showed an uncompetitive type of inhibition, whereby there was a reduction in both and . As presented in Table 2, in the presence of EO was reduced from mg to mg and from mg mL−1 sec−1 to mg mL−1 sec−1. Similarly, was reduced from mg to mg and from mg mL−1 sec−1 to mg mL−1 sec−1 in the presence of methanolic AM. In contrast, in the presence of EL, was raised from mg to mg while was reduced to mg mL−1 sec−1.
3.3. α-Glucosidase Inhibition In Vitro
α-Glucosidase activity was assessed by the release of p-nitrophenol from PNPG in vitro. IC50 (μg/mL) values of active extracts are presented in Table 3. Tested extracts exhibited various levels of effectiveness in inhibiting α-glucosidase. It was observed that both methanolic and aqueous extracts of EL, EO, AM, and SL were potent inhibitors (1.02–185.92 μg/mL) of α-glucosidase compared to acarbose (5115.73 μg/mL).
| bValues significantly () lower than control (acarbose); methanolic extracts; ( ) aqueous extracts.|
3.4. α-Glucosidase Kinetic Studies
Table 4 presents the and values of active plants extracts against α-glucosidase. A decrease in both and as compared to the uninhibited reaction ( mM (), mg mL−1 sec−1 ()) was noted for all tested extracts.
| methanolic extracts; ( ) aqueous extracts.|
3.5. Glucose Movement
Glucose movement for the control experiment (without plant extract) showed a mean glucose concentration of 0.906 mM. From Figures 1 and 2, it was observed that there was no apparent difference in glucose diffusion inhibition between the different types of extracts. As shown in Table 5, studied extracts exhibited glucose diffusion retardation index (GDRI) between 8 and 29%. Furthermore, it was observed that methanolic extracts were more potent inhibitors of glucose movement.
| 1Values are mean ± SD of triplicate determinations; cvalues significantly () different from negative control; 2GDRI expressed as percentage; GDRI ± SD was calculated from triplicate determinations; methanolic extracts; ( ) aqueous extracts.|
Dose-dependent studies on the effect of extracts on glucose retarding activity revealed a concentration-dependent inhibitory action (Figure 3). GDRI (%) decreased with decreasing plant extract concentration. SL was found to exhibit greater GDRI at all concentrations tested.
3.6. Amylolysis Kinetics
Figures 4 and 5 summarise the starch concentration (%) of the reaction mixture inside the dialysis bag and the glucose concentration (mM) of the surrounding solution after 4 h. Methanolic extracts were found to be potent inhibitors compared to their corresponding aqueous extracts. As observed by the α-amylase inhibition assay, methanolic EL, EO, and AM gave the best inhibitory activity since starch concentration was the highest in the presence of these extracts (Figure 5). Glucose dialysis was the least in the presence of methanolic SL extract.
The present study was geared towards investigating the potential effects of selected medicinal plants of Mauritius to inhibit key carbohydrate hydrolysing enzymes, namely, α-amylase and α-glucosidase. Furthermore, the ability of the extracts to entrap glucose and amylolysis kinetics were also evaluated. α-Amylase and α-glucosidase are key carbohydrate hydrolysing enzymes responsible for breaking α,1-4 bonds in disaccharides and polysaccharides, liberating glucose [18, 19]. The glucose surge observed a few minutes after ingestion contributes to hyperglycaemia, the hallmark of DM. Several scientific studies have shed light on the inhibition of these key glycoside hydrolases to slow down carbohydrate digestion, reducing glucose absorption rate, consequently preventing postprandial glucose surge [20, 21]. The ability of plant extracts to modulate glucose liberation from starch and its absorption  has proved to be an attractive therapeutic modality in the management of DM. Polyphenolic compounds found in extracts have also been reported to interact with proteins and hence inhibit enzymatic activity [10, 22].
Results from this study tend to show that extracts of selected medicinal plants showed variable inhibitory effect on α-amylase and α-glucosidase in vitro. It was observed that three methanolic extracts (EL, EO, and AM) possessed dose-dependent α-amylase inhibitory activity. From data amassed, it was obvious that methanolic fractions carried higher concentration of inhibitory phytochemicals as previously reported [9, 23]. Furthermore, several scientific reports highlight the inhibitory action of plant phytochemicals on α-amylase [23, 24]. Additionally, the kinetic model of these extracts on α-amylase was studied and it was found that in the presence of methanolic extracts of EO and AM, a decrease in both (the affinity of the enzymes for the substrate) and (the velocity of reaction) were observed. This tends to suggest an uncompetitive mode of inhibition. Uncompetitive inhibitors bind to enzyme-substrate complex forming an enzyme-substrate-inhibitor complex [25, 26]. This complex reduces affinity for the enzyme active site for the substrate decreasing the affinity and delays rate of reaction [14, 27]. It was also noted that active extracts uncompetitively inhibited α-glucosidase. Furthermore, α-glucosidase inhibitory assay tends to show that extracts of medicinal plants were potent inhibitors of α-glucosidase as compared to acarbose. This finding was consistent with Shai et al.  who reported the little inhibitory action of acarbose on α-glucosidase. In contrast, methanolic extract of EL was found to follow mixed type of inhibition. Mixed inhibitor bind to free and to substrate bound enzyme and interfere with binding and catalysis of substrate [25, 26], increasing affinity and decreasing reaction rate . Retarding glucose production and/or absorption might be important strategies in the management of diabetes.
We also investigated the effect of selected medicinal plants on glucose entrapment in vitro. A number of studies have unravelled the value of plants complex polysaccharides such as guar gum, oats, and psyllium husk in lowering blood glucose level . The retardation in glucose diffusion in vivo might be attributed to the physical obstacles, insoluble fibre particles, which entrap glucose molecules within the fibre network preventing postprandial glucose rise [17, 29]. They form a viscous matrix which delay gastric emptying and slow glucose uptake [17, 30]. The viscous gel also impedes the access of glucose to the small intestines’ epithelium, blunting postprandial glucose peaks. GDRI, a useful in vitro index to predict the effect of fibres present in the extracts on the delay in glucose absorption, was calculated in this study [24, 31]. SL was found to have the highest GDRI value. Similarly, Wood et al.  reported that plants showing between 6 and 48% inhibitory action on glucose diffusion across a semipermeable membrane possessed moderate inhibitory activity. Furthermore, widely studied sources of soluble fibres such as wheat bran, oats, and psyllium husk were found to inhibit between 10 and 23% glucose diffusion after 180 min in vitro . However, in the present study we observed that SL was a poor α-amylase inhibitor. It could be argued that the antidiabetic action of SL might be due to this glucose movement retardation properties rather than α-amylase inhibition. Further studies demonstrated that glucose movement retardation properties were dose dependent. Published literature highlight the effect of soluble fibre’s molecular weight and concentration along with viscosity on modulating glucose dialysis [11, 33]. Another possible mechanism is the sequestration of enzymatic activity on carbohydrates. As reported from previous study amylolysis assay showed that the retardation of glucose diffusion is also due to the inhibition of α-amylase, thus limiting the release of glucose from starch . The inhibition of α-amylase might be due to the concerted action of encapsulation of the enzyme and/or starch in the fiber matrix and/or the action of inhibitors. Eventually, this leads to reduced glucose absorption and blunting of postprandial glucose rise .
The present study demonstrated the ability of native antidiabetic medicinal plants of Mauritius to inhibit key carbohydrate hydrolysing enzymes and unravelled their mode of inhibition. Furthermore, to date no such study has been conducted to evaluate the glucose entrapment properties and amylolysis kinetic effects of these extracts. Data gathered suggest that methanolic fractions of EO, EL, and AM were active enzyme inhibitors. Pertaining to the role of these enzymes in the control of post-prandial increase of blood glucose level, their inhibition could be useful in the development of new drug strategies. Further scientific validation is essential to understand the therapeutic potential of these medicinal plants for improving glycaemic control in diabetic subjects and confirm their antidiabetic mode of action.
Conflict of Interests
The authors declare that there is no conflict of interests.
The authors acknowledge the University of Mauritius and the Tertiary Education Commission for financial support.
- V. K. Prabhakar, A. Jaidka, and R. Singh, “In vitro study on α-amylase inhibitory activity and phytochemical screening of few Indian medicinal plant having anti-diabetic properties,” International Journal of Scientific and Research Publications, vol. 3, no. 8, pp. 1–6, 2013.
- Ministry of Health and Quality of life (MOH), “The trends in diabetes and cardiovascular disease risk in Mauritius,” The Mauritius Non Communicable Disease Survey 2009, 2009, http://health.gov.mu/English/Documents/ncd-2009.pdf.
- International Diabetes Federation, IDF Diabetes Atlas, 5th edition, 2013, http://www.idf.org/diabetesatlas/5e/the-global-burden.
- P. Pasupathi, V. Chandrasekar, and U. S. Kumar, “Evaluation of oxidative stress, enzymatic and non-enzymatic antioxidants and metabolic thyroid hormone status in patients with diabetes mellitus,” Diabetes and Metabolic Syndrome: Clinical Research & Reviews, vol. 3, no. 3, pp. 160–165, 2009.
- B. Mayur, S. Sandesh, S. Shruti, and S. Sung-Yum, “Antioxidant and α-glucosidase inhibitory properties of Carpesium abrotanoides L.,” Journal of Medicinal Plants Research, vol. 4, pp. 1547–1553, 2010.
- S. Pennathur and J. W. Heinecke, “Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy,” Frontiers in Bioscience, vol. 9, pp. 565–574, 2004.
- A. Mootoosamy and M. F. Mahomoodally, “Ethnomedicinal application of native remedies used against diabetes and related complications in Mauritius,” Journal of Ethnopharmacology, vol. 10, pp. 413–444, 2014.
- S. Gurudeeban, K. Satyavani, and T. Ramanathan, “Alpha glucosidase inhibitory effect and enzyme kinetics of coastal medicinal plants,” Bangladesh Journal of Pharmacology, vol. 7, pp. 186–191, 2012.
- M. F. Mahomoodally, A. H. Subratty, A. Gurib-Fakim, M. I. Choudary, and S. N. Khan, “Traditional medicinal herbs and food plants have the potential to inhibit key carbohydrates hydrolyzing enzymes in vitro and reduce postprandial blood glucose peaks in vivo,” The Scientific World Journal, vol. 2012, Article ID 285284, 9 pages, 2012.
- E. Thilagam, B. Parimaladevi, C. Kumarappan, and S. C. Mandal, “α-glucosidase and α-amylase inhibitory activity of Senna surattensis,” Journal of Acupuncture and Meridian Studies, vol. 6, pp. 24–30, 2013.
- C. A. Edwards, N. A. Blackburn, and L. Craigen, “Viscosity of food gums determined in vitro related to their hypoglycemic actions,” American Journal of Clinical Nutrition, vol. 46, no. 1, pp. 72–77, 1987.
- A. Gurib-Fakim, J. Gueho, and M. D. Sewraj, Plantes Medicinales de Maurice, vol. 1, Editions de L'ocean Indien, Stanley, Rose Hill, Mauritius, 1996.
- M. I. Kotowaroo, M. F. Mahomoodally, A. Gurib-Fakim, and A. H. Subratty, “Screening of traditional antidiabetic medicinal plants of Mauritius for possible α-amylase inhibitory effects in vitro,” Phytotherapy Research, vol. 20, no. 3, pp. 228–231, 2006.
- J. A. Bachhawat, M. S. Shihabudeen, and K. Thirumurugan, “Screening of Fifteen Indian ayurvedic plants for alpha-glucosidase inhibitory activity and enzyme kinetics,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 3, no. 4, pp. 267–274, 2011.
- S. Shaukat, A. Waqar, and M. A. Waqar, “Investigating the influence of folk anti-diabetic plants on glucose diffusion,” Journal of the Chemical Society of Pakistan, vol. 31, no. 3, pp. 480–484, 2009.
- A. M. Gallagher, P. R. Flatt, G. Duffy, and Y. H. A. Abdel-Wahab, “The effects of traditional antidiabetic plants on in vitro glucose diffusion,” Nutrition Research, vol. 23, no. 3, pp. 413–424, 2003.
- F. Ahmed, S. Sairam, and A. Urooj, “In vitro hypoglycemic effects of selected dietary fiber sources,” Journal of Food Science and Technology, vol. 48, no. 3, pp. 285–289, 2011.
- S. S. Gropper and J. L. Smith, Advanced Nutrition and Human Metabolism, Cengage Learning, Hampshire, UK, 2012.
- S. R. Rolfes, K. Pinna, and E. Whitney, Understanding Normal and Clinical Nutrition, Cengage Learning Inc., Belmont, Calif, USA, 2008.
- R. Rhabasa-Lhoret and J. L. Chiasson, “Alpha-glucosidase inhibition,” in International Textbook of Diabetes Mellitus, R. A. Defronzo, E. Ferrannini, H. Keen, and P. Zimmet, Eds., pp. 901–914, John Wiley & Sons, London, UK, 2004.
- G. Oboh, A. O. Ademosun, O. V. Odubanjo, and I. A. Akinbola, “Antioxidative properties and inhibition of key enzymes relevant to type-2 diabetes and hypertension by essential oils from black pepper,” Advances in Pharmacological Sciences, pp. 1–6, 2013.
- R. Sharma, Enzyme Inhibition and Bio Applications, In Tech, Beijing, China, 2012.
- K. Sama, K. Murugesan, and R. Sivaraj, “In vitro alpha amylase and alpha glucosidase inhibition activity of crude ethanol extract of Cissus arnottiana,” Asian Journal of Plant Science and Research, vol. 2, no. 4, pp. 550–553, 2012.
- R. McEwan, R. P. Madivha, T. Djarova, O. A. Oyedeji, and A. R. Opoku, “Alpha-amylase inhibitor of amadumbe (Colocasia esculenta): isolation, purification and selectivity toward α-amylases from various sources,” African Journal of Biochemistry Research, vol. 4, no. 9, pp. 220–224, 2010.
- A. Cornish-Bowden, Fundamentals of Enzyme Kinetics, John Wiley & Sons, London, UK, 2013.
- H. Bisswanger, Enzyme Kinetics, John Wiley & Sons, 2008.
- A. Cornish-Bowden, “A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non competitive inhibitors,” Biochemical Journal, vol. 137, no. 1, pp. 143–144, 1974.
- L. J. Shai, P. Masoko, M. P. Mokgotho et al., “Yeast alpha glucosidase inhibitory and antioxidant activities of six medicinal plants collected in Phalaborwa, South Africa,” South African Journal of Botany, vol. 76, no. 3, pp. 465–470, 2010.
- S. K. Basha and V. S. Kumari, “In vitro antidiabetic activity of psidium guajava leaves extracts,” Asian Pacific Journal of Tropical Diseases, pp. 98–100, 2012.
- C. Palanuvej, S. Hokputsa, T. Tunsaringkarn, and N. Ruangrungsi, “In vitro glucose entrapment and alpha-glucosidase inhibition of mucilaginous substances from selected Thai medicinal plants,” Scientia Pharmaceutica, vol. 77, no. 4, pp. 837–849, 2009.
- F. Ahmed, N. S. Siddaraju, and A. Urooj, “In vitro hypoglycemic effects of Gymnema sylvestre, Tinospora cordifolia, Eugenia jambolana and Aegle marmelos,” Journal of Natural Pharmaceuticals, vol. 2, no. 2, pp. 52–55, 2011.
- P. J. Wood, M. U. Beer, and G. Butler, “Evaluation of role of concentration and molecular weight of oat β-glucan in determining effect of viscosity on plasma glucose and insulin following an oral glucose load,” British Journal of Nutrition, vol. 84, no. 1, pp. 19–23, 2000.
- A. Srichamroen and V. Chavasit, “In vitro retardation of glucose diffusion with gum extracted from malva nut seeds produced in Thailand,” Food Chemistry, vol. 127, no. 2, pp. 455–460, 2011.
Copyright © 2014 Carene M. N. Picot et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.